Establishment Labs (NASDAQ:ESTA) Trading 10.1% Higher – Still a Buy?

Establishment Labs Holdings Inc. (NASDAQ:ESTA) shares shot up 10.1% during mid-day trading on Thursday . The stock traded as high as $33.51 and last traded at $33.21. 434,547 shares changed hands during trading, a decline of 33% from the average session volume of 644,690 shares. The stock had previously closed at $30.16.

Analysts Set New Price Targets

Separately, Stephens raised Establishment Labs to a “strong-buy” rating in a research report on Monday, December 2nd. One analyst has rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, Establishment Labs presently has a consensus rating of “Buy” and a consensus target price of $60.60.

Establishment Labs Stock Performance

The firm has a market capitalization of $1.01 billion, a price-to-earnings ratio of -13.98 and a beta of 1.12. The firm has a 50 day moving average price of $38.86 and a 200-day moving average price of $41.55. The company has a debt-to-equity ratio of 5.94, a current ratio of 3.62 and a quick ratio of 2.29.

Institutional Investors Weigh In On Establishment Labs

Hedge funds have recently bought and sold shares of the stock. Capital Research Global Investors raised its holdings in Establishment Labs by 29.3% in the fourth quarter. Capital Research Global Investors now owns 1,911,525 shares of the company’s stock valued at $88,064,000 after acquiring an additional 433,484 shares in the last quarter. William Blair Investment Management LLC raised its holdings in shares of Establishment Labs by 44.1% in the 4th quarter. William Blair Investment Management LLC now owns 812,825 shares of the company’s stock valued at $37,447,000 after purchasing an additional 248,888 shares in the last quarter. Rice Hall James & Associates LLC lifted its position in shares of Establishment Labs by 10.7% during the 3rd quarter. Rice Hall James & Associates LLC now owns 793,300 shares of the company’s stock worth $34,326,000 after purchasing an additional 76,959 shares during the last quarter. Boothbay Fund Management LLC grew its stake in shares of Establishment Labs by 68.8% during the fourth quarter. Boothbay Fund Management LLC now owns 525,248 shares of the company’s stock worth $24,198,000 after purchasing an additional 214,119 shares in the last quarter. Finally, Bamco Inc. NY increased its holdings in Establishment Labs by 13.6% in the third quarter. Bamco Inc. NY now owns 489,386 shares of the company’s stock valued at $21,176,000 after buying an additional 58,611 shares during the last quarter. Institutional investors and hedge funds own 72.91% of the company’s stock.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.